SVR 24 Achievement Two Weeks After a Tripled Dose of Daclatasvir in an HCV Genotype 3 Patient

Title
SVR 24 Achievement Two Weeks After a Tripled Dose of Daclatasvir in an HCV Genotype 3 Patient
Authors
Keywords
-
Journal
Annals of Hepatology
Volume 17, Issue 4, Pages 661-664
Publisher
Index Copernicus
Online
2018-06-12
DOI
10.5604/01.3001.0012.0950

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now